An Eight-Week Study to Evaluate the Safety and Efficacy of VSJ-110 Compared to Placebo in the Treatment of Dry Eye
Clinical trial NCT07179055 · RECRUITING
Trial details
- NCT number
- NCT07179055
- Sponsor
- Vanda Pharmaceuticals
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-10-01
- Primary completion
- 2026-09-01
- Enrollment
- 160
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.